ArticleTranslational oncology2021

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation.

Brendan P Hodkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.